Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-022192
Filing Date
2025-03-10
Accepted
2025-03-10 16:06:58
Documents
106
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0232483-20f_purple.htm   iXBRL 20-F 2800603
2 DESCRIPTION OF SHARE CAPITAL ea023248301ex2-1_purple.htm EX-2.1 105434
3 INSIDER TRADING POLICY ea023248301ex4-23_purple.htm EX-4.23 48979
4 LIST OF SUBSIDIARIES OF THE REGISTRANT ea023248301ex8-1_purple.htm EX-8.1 5801
5 CERTIFICATION ea023248301ex12-1_purple.htm EX-12.1 10203
6 CERTIFICATION ea023248301ex13-1_purple.htm EX-13.1 4330
7 CONSENT OF SOMEKH CHAIKIN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, A MEMB ea023248301ex15-1_purple.htm EX-15.1 2021
8 GRAPHIC image_001.jpg GRAPHIC 97310
9 GRAPHIC image_002.jpg GRAPHIC 44748
10 GRAPHIC image_003.jpg GRAPHIC 45546
  Complete submission text file 0001213900-25-022192.txt   10426767

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE ppbt-20241231.xsd EX-101.SCH 98731
12 XBRL CALCULATION FILE ppbt-20241231_cal.xml EX-101.CAL 52279
13 XBRL DEFINITION FILE ppbt-20241231_def.xml EX-101.DEF 346142
14 XBRL LABEL FILE ppbt-20241231_lab.xml EX-101.LAB 624157
15 XBRL PRESENTATION FILE ppbt-20241231_pre.xml EX-101.PRE 355297
109 EXTRACTED XBRL INSTANCE DOCUMENT ea0232483-20f_purple_htm.xml XML 1505866
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-37643 | Film No.: 25723704
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)